… We have also made a lot of progress in advancing our innovation pipeline", said Daniel de Boer, Chief Executive … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… progress in all of our programs as well as in our innovation efforts. Our QR-010 program for CF has completed … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… 6 at 11:00am ET Gerard Platenburg, co-founder and Chief Innovation Officer of ProQR will present our proprietary RNA … in RNA,” said Gerard Platenburg, co-founder and Chief Innovation Officer of ProQR. “With this approach …
… Aartsma-Rus. The SAB, chaired by Gerard Platenburg, Chief Innovation Officer of ProQR, will play a key strategic role … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
… SAB, which is chaired by Gerard Platenburg, Chief Innovation Officer of ProQR, now consists of six members … of ophthalmic indications,” said Gerard Platenburg, Chief Innovation Officer at ProQR. “ProQR’s RNA-based approach …
… Aartsma-Rus, and is chaired by Gerard Platenburg, Chief Innovation Officer of ProQR. LEIDEN, the Netherlands, April … scientific advisory board,” said Gerard Platenburg, Chief Innovation Officer at ProQR. “Particularly exciting for us is …
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expects up to four clinical data readouts in 2025 and 2026 across multi